Lincoln Pharmaceuticals Ltd share price logo

Lincoln Pharmaceuticals Ltd Share Price (LINCOLN)

₹579.9▲0.15%

bell
Get free price alerts. Set up your Free investment account to get Live Prices. >
Overview
Fundamentals
Q3 '23 Results
Technicals
News and Events

Lincoln Pharmaceuticals Ltd share Performance

  • ₹577.1
    ₹589.45
    ₹579.9
    downward going graph

    0.48%

    Low

    Day's Volatility:2.13%

    High

    1.65%

    downward going graph
  • ₹365.25
    ₹755.15
    ₹579.9
    downward going graph

    37.02%

    Low

    52 Weeks Volatility:67.24%

    High

    30.22%

    downward going graph
1 Month Return0.62 %
3 Month Return-13.95 %
1 Year Return47.79 %
Previous Close₹580.80
Open₹586.15
Volume24.45K
Upper Circuit-
Lower Circuit-
Market Cap₹1,163.33Cr

Company Information

Lincoln Pharmaceuticals, established in January 1979 as a partnership firm, was converted into a public limited company in January 1995. Primarily set up to manufacture pharmaceutical formulations such as tablets, capsules, syrups and ointments, they also obtained products from other licensed manufacturers to meet the demands of small volume parenterals. In order to increase production capacity, the company set up a modern formulation plant in Khatraj, Gujarat, and established an in-house laboratory for quality control and R&D. To fund its projects, the firm launched a public issue in February 1996, and in the year 2000, they were granted ISO 9002 and WHO certification. As a result, Lincoln Pharmaceuticals is now a leading manufacturer of quality pharmaceuticals that is continuously working to improve its operations.

Share Price: ₹579.90 per share as on 18 Apr, 2024 04:01 PM
Market Capitalisation: ₹1,163.33Cr as of today
Revenue: ₹146.45Cr as on December 2023 (Q4 23)
Net Profit: ₹28.04Cr as on December 2023 (Q4 23)
Listing date: 17 Dec, 2015
Chairperson Name: Kishorbhai M Shah
OrganisationLincoln Pharmaceuticals Ltd
HeadquartersAhmedabad
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Lincoln Pharmaceuticals Ltd

  • Lincoln Pharmaceuticals Ltd's P/E Ratio Suggests Strong Buy - 14 Mar, 2024

    Lincoln Pharmaceuticals Ltd's P/E ratio of 12.9x is lower than the market average, but investors may be concerned about its future earnings growth potential. However, the company has been growing earnings at a solid pace and could potentially be a good buy for those who believe in its growth prospects.

Fundamentals of Lincoln Pharmaceuticals Ltd

Insights on Lincoln Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 46.88% to 46.91% in Dec 2023 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 12.56 Cr → 28.04 Cr (in ₹), with an average increase of 22.2% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 2.59% to 3.23% in Dec 2023 quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, LINCOLN has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Sun Pharmaceuticals Industries Ltd has given 53.0% return, outperforming this stock by 5.2%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, LINCOLN stock has moved down by -3.1%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 50.53% to 49.80% in Dec 2023 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 164.68 Cr → 157.47 Cr (in ₹), with an average decrease of 4.4% per quarter

Lincoln Pharmaceuticals Ltd Valuation

Lincoln Pharmaceuticals Ltd in the last 5 years

  • Overview

  • Trends

Lowest (3.58x)

March 23, 2020

Today (13.33x)

April 16, 2024

Industry (60.97x)

April 16, 2024

Highest (18.47x)

January 23, 2018

LowHigh

Shareholding Pattern

InvestorsHoldings %Prev. 4 periods3M change
Promoter Holdings
49.8%
-1.43
Foreign Institutions
3.23%
24.72
Mutual Funds
0%
0.00
Retail Investors
46.91%
0.05
Others
0.06%
0.00

Technicals of Lincoln Pharmaceuticals Ltd share

News & Events of Lincoln Pharmaceuticals Ltd

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Lincoln Pharmaceuticals Ltd shares.

Lincoln Pharmaceuticals Ltd (LINCOLN) share price today is ₹579.9

Lincoln Pharmaceuticals Ltd is listed on NSE

Lincoln Pharmaceuticals Ltd is listed on BSE

  • Today’s highest price of Lincoln Pharmaceuticals Ltd is ₹589.45.
  • Today’s lowest price of Lincoln Pharmaceuticals Ltd is ₹577.1.

PE Ratio of Lincoln Pharmaceuticals Ltd is 13.33

PE ratio = Lincoln Pharmaceuticals Ltd Market price per share / Lincoln Pharmaceuticals Ltd Earnings per share

Today’s traded volume of Lincoln Pharmaceuticals Ltd(LINCOLN) is 24.45K.

Today’s market capitalisation of Lincoln Pharmaceuticals Ltd(LINCOLN) is ₹1163.33Cr.

Lincoln Pharmaceuticals Ltd(LINCOLNPrice
52 Week High
₹755.15
52 Week Low
₹365.25

Lincoln Pharmaceuticals Ltd(LINCOLN) share price is ₹579.9. It is down -23.21% from its 52 Week High price of ₹755.15

Lincoln Pharmaceuticals Ltd(LINCOLN) share price is ₹579.9. It is up 58.77% from its 52 Week Low price of ₹365.25

Lincoln Pharmaceuticals Ltd(LINCOLNReturns
1 Day Returns
-0.9%
1 Month Returns
0.62%
3 Month Returns
-13.95%
1 Year Returns
47.79%